Artiva Biotherapeutics, Inc.(ARTV)
盘后12.54-0.01-0.05%19:50 EDT
12.55+0.44+3.63%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Artiva Biotherapeutics, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤（NK）细胞的疗法。- 03-10Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03-10Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 03-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-24Form 8-K - Current report重要事件披露Form 8-K - Current report
- 02-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-12-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-17Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-12Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-17Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-14Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-08-06Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
13.20
今开
12.68
量比
1.36
最低
11.11
昨收
12.11
换手率
13.87%